# R Retreatment in 1st Relapsed DLBCL

> **NCT00980304** · PHASE2 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine**

## Conditions studied

- Lymphomas

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00980304
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980304, "R Retreatment in 1st Relapsed DLBCL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00980304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*